89bio Inc (ETNB)
8.38
+0.40
(+5.01%)
USD |
NASDAQ |
Nov 21, 16:00
8.38
0.00 (0.00%)
After-Hours: 20:00
89bio Shareholders Equity (Quarterly): 378.10M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 378.10M |
| June 30, 2024 | 514.92M |
| March 31, 2024 | 510.54M |
| December 31, 2023 | 536.31M |
| September 30, 2023 | 410.21M |
| June 30, 2023 | 441.99M |
| March 31, 2023 | 445.83M |
| December 31, 2022 | 151.83M |
| September 30, 2022 | 152.58M |
| June 30, 2022 | 80.18M |
| March 31, 2022 | 102.74M |
| December 31, 2021 | 125.96M |
| Date | Value |
|---|---|
| September 30, 2021 | 146.77M |
| June 30, 2021 | 172.70M |
| March 31, 2021 | 190.20M |
| December 31, 2020 | 202.96M |
| September 30, 2020 | 214.00M |
| June 30, 2020 | 69.77M |
| March 31, 2020 | 79.90M |
| December 31, 2019 | 89.94M |
| September 30, 2019 | -53.97M |
| June 30, 2019 | 12.81M |
| December 31, 2018 | -16.06M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
69.77M
Minimum
Jun 2020
536.31M
Maximum
Dec 2023
250.87M
Average
181.45M
Median
Shareholders Equity (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 777.16M |
| Eli Lilly and Co | 14.24B |
| Viking Therapeutics Inc | 911.45M |
| Akero Therapeutics Inc | 738.32M |
| NovaBay Pharmaceuticals Inc | 1.072M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 458.30M |
| Total Liabilities (Quarterly) | 80.20M |